Description
MOTS-c is a 16–amino-acid mitochondrial-derived peptide (MDP) that acts as a metabolic regulator, primarily through AMPK activation. Preclinical studies show it enhances insulin sensitivity, promotes fat oxidation, improves exercise capacity, and counters age-related metabolic decline. No clinical trials have been completed in humans to date. This educational protocol presents a once-daily subcutaneous approach with gradual titration.
There are no reviews yet.